https://ift.tt/2IVHF6y

The stock has dipped 8% to Rs 558 on the BSE after the pharmaceutical company posted 11% decline in its consolidated net profit at Rs 3.77 billion for Q2FY19.

from Markets https://ift.tt/2PASpKf

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads